Generic medicines: Perceptions of general practitioners in Melbourne, Australia

Journal of Generic Medicines

Volumn 3, Issue 3, 2006, Pages 214-225

  Hassali, Mohamed Azmi ^a   Kong, David C M ^b,c   Stewart, Kay ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

ADULT; ARTICLE; AUSTRALIA; CONTENT ANALYSIS; CONVENIENCE SAMPLE; DRUG EFFICACY; DRUG INDUSTRY; DRUG LABELING; DRUG MARKETING; DRUG SAFETY; DRUG SUBSTITUTION; DRUG UTILIZATION; FEMALE; FINANCIAL MANAGEMENT; GENERAL PRACTICE; GENERAL PRACTITIONER; GOVERNMENT; HUMAN; INFORMATION DISSEMINATION; KNOWLEDGE; MALE; MEDICAL EDUCATION; MEDICAL STUDENT; PATIENT ATTITUDE; PATIENT EDUCATION; PHARMACIST ATTITUDE; PHYSICIAN ATTITUDE; PRESCRIPTION; QUALITATIVE ANALYSIS; SEMI STRUCTURED INTERVIEW;

EID: 33751560412     PISSN: 17411343     EISSN: 17417090     Source Type: Journal    
DOI: 10.1057/palgrave.jgm.4940122     Document Type: Article

References (48)

1. Hall, J. (1999) 'Incremental change in the Australian health care system', Health Affairs, Vol. 18, pp. 95-110.
2. Smeaton, J. (2000) 'The generics market', Australian Journal of Pharmacy, Vol. 81, pp. 540-542.
3. Commonwealth Department of Health and Ageing (2004) 'PBS prescription volume and governmenH cost, year ending: June 2004', available at: http://www.health.gov.au/internet/wcms/Publishing.nsf/Content/ health-pbs-general-pubs-pbbexp-jun04.htm/$FILE/bookp01.pdf. Accessed 30th August, 2004.
4. Harvey, K. J. (2002) 'Securing the future of the pharmaceutical benefits scheme? The drawing board: An Australian review of public affairs', School of Economics and Political Science, University of Sydney, available at: http://www.econ.usyd.edu.au/drawingboard/. Accessed 30th September, 2002.
5. Sweeny, K. (2002) 'Trends in the use and cost of pharmaceuticals under the pharmaceutical benefits scheme', Working Paper No. 5, Pharmaceutical Industry Project Equity, Sustainability and Industry Development Working Paper Series. Centre for Strategic Economic Studies, Victoria University of Technology, Melbourne, Australia; pp. 1-12.
6. McGavock, H. (2001) 'Generic substitution: Issues relating to the Australian experience', Pharmacoepidemiology and Drug Safety, Vol. 10, pp. 555-556.
7. Lofgren, H. (2004) 'Generics drugs: International trends and policy developments in Australia', Australian Health Review, Vol. 27, pp. 39-48.
8. Karim, S., Pillai, G., Ziqubu-Page, T. T. et al. (1996) 'Potential savings from generic prescribing and generic substitution in South Africa', Health Policy and Planning, Vol. 11, pp. 198-205.
9. Tilyard, M. W. and Dovey, S. M. (1990) 'General practitioners' views on generic medication and substitution', New Zealand Medical Journal, Vol. 103, pp. 318-320.
10. King, D. R. and Kanavos, P. (2002) 'Encouraging the use of generic medicines: Implications for transition economies', Croatian Medical Journal, Vol. 43, pp. 462-469.
11. Moulds, R. (1992) 'Generic prescribing - the pros', Australian Prescriber, Vol. 15, p. 50.
12. Messenger, A. (1995) 'Substitution bitter pill to swallow for some', Australian Doctor, June 4, p. 16.
13. Donovan, J. (2003) 'Is there a role for generic medicines in the pharmaceutical benefits scheme?', Health Issues (Melbourne, Australia), Vol. 75, pp. 9-11.
14. Brand, P., Clear, P., Keen, S. et al. (1995) 'Brand substitution', Australian Pharmacist, Vol. 14, pp. 646-649.
15. Kirking, D. M., Gaither, C. A., Ascione, F. J. and Welage, L. S. (2001) 'Physicians' individidual and organizational views on generic medications', Journal of the American Pharmaceutical Association, Vol. 41, pp. 718-722.
16. Berg, B. (1998) 'Designing qualitative research', in: Qualitative research methods for the social sciences', 5th edn, Allyn & Bacon, Boston, MA, p. 37.
17. Smith, F. (1998) 'Health services research methods in pharmacy - Qualitative interviews', International Journal of Pharmacy Practice, Vol. 6, pp. 97-108.
18. Morse, J. (1995) 'The significance of saturation', Qualitative Health Research, Vol. 5, pp. 147-149.
19. Glazer, B. G. and Strauss, A. L. (1967) 'The discovery of grounded theory: Strategies for qualitative research', Aldine, New York, NY.
20. Berg, B. (1998) 'A dramaturgical look at interviewing', in 'Qualitative research methods for social sciences', 5th edn, Allyn & Bacon, Boston, MA, p. 86.
21. Pope, C., Ziebland, S. and Mays, N. (2000) 'Analysing qualitative data', British Medical Journal, Vol. 320, pp. 114-116.
22. Mays, N. and Pope, C. (1995) 'Qualitative research: Rigour and qualitative research', British Medical Journal, Vol. 311, pp. 109-112.
23. Britt, H., Miller, G., Knox, S. et al. (2003) 'General practice activity in Australia 2002-03', General Practice Series No.14, Australian Institute of Health and Welfare, Canberra, Australia.
24. Scuderi, M. (2002) 'Generic substitution in a Brisbane community pharmacy', Australian Pharmacist, Vol. 21, pp. 116-121.
25. Birkett, D. J. (2003) 'Generics equal or not?', Australian Prescriber, Vol. 26, pp. 85-87.
26. Bengzon, A. (1991) 'National drug policy: International perspectives', Australian Prescriber, Vol. 14(Suppl 1), pp. 6-11.
27. Medicine Control Authority (2002) 'Best practice guidance on the labelling and packaging of medicines', Medicine Control Agency of United Kingdom, available at: http://medicines.mhra.gov.uk/inforesources/ publications/bpglabpack.pdf. Accessed 30th August, 2002.
28. Probyn, A. (2004) 'Some drugs more equal than others: Pseudo-generics and commercial practice', Australian Health Review, Vol. 28, pp. 207-217.
29. Harvey, K. (2005) 'The Pharmaceutical Benefits Scheme 2003-2004', Australia and New Zealand Health Policy, Vol. 2, pp. 1-6, available at http://www.pubmedcentral.nih.gov/picrender.fcgiartid= 548296&blobtype=pdf. accessed 15th January, 2005.
30. Nolan, A. (2000) 'Pharmaceutical advertising in clinical software', Australian Prescriber, Vol. 23, pp. 52-53.
31. Limprecht, E. (2005) 'GPs split on software ads', Australian Doctor, 11th March, pp. 1-2.
32. Newby, D., Fryer, J. and Henry, D. (2003) 'Effect of computerised prescribing on use of antibiotics', Medical Journal of Australia, Vol. 178, pp. 210-221.
33. Burton, B. (2003) 'Changing prescription software to favour generics could save Australia 40 million pounds a year', British Medical Journal, Vol. 326, p. 184.
34. Komesaroff P. and Kerridge, I. (2002) 'Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry', Medical Journal of Australia, Vol. 176, pp. 118-121.
35. Newby, D. A. and Henry, D. A. (2002) 'Drug advertising: Truths, half-truths and few statistics', Medical Journal of Australia, Vol. 177, pp. 285-286.
36. Wazana, A. (2000) 'Physicians and the pharmaceutical industry. Is a gift ever just a gift?', Journal of the American Medical Association, Vol. 283, pp. 373-380.
37. Kanavos, P. (1999) 'Financing pharmaceuticals in transition economies', Croatian Medical Journal, Vol. 40, pp. 244-259.
38. Whynes, D., Baines, D. and Tolley, K. (1997) 'GP fundholding and the costs of prescribing: Further results', Journal of Public Health Medicine, Vol. 19, pp. 18-22.
39. Wilson, R. P. H., Buchan, I. and Walley, T. (1995) 'Alterations in prescribing by general practitioner fundholders: An observational study', British Medical Journal, Vol. 311, pp. 1347-1350.
40. Bateman, D. N., Campbell, M., Donaldson, L. J. et al. (1996) 'A prescribing incentive scheme for non-fundholding general practices: An observational study', British Medical Journal, Vol. 313, pp. 535-538.
41. Newby, D. A., Hill, S. R., Barker, B. J. et al. (2001) 'Drug information for consumers: Should it be disease or medication specific? Results of a community survey', Australian and New Zealand Journal of Public Health, Vol. 25, pp. 564-570.
42. McGettigan, P., McManus, J., O'Shea, B. et al. (1997) 'Low rate of generic prescribing in the Republic of Ireland compared to England and Northern Ireland: Prescribers' concerns', Irish Medical Journal, Vol. 90, pp. 146-147.
43. Maimon, C. (2000) 'A new era for generic pharmaceuticals', US Pharmacist, November (Suppl), pp. 14-15; 22-23; 28.
44. Meadows, M. (2003) 'Greater access to generic drugs. New FDA initiatives to improve drug reviews and reduce legal loopholes', FDA Consumer, Vol. 37, pp. 12-17.
45. Campbell, M., Smith, M. and Beaney, A. (1995) 'The pros and cons of generic medicines', Pharmacoeconomics, Vol. 8, pp. 362-364.
46. Armstrong, D., Reyburn, H. and Jones, R. (1996) 'A study of general practitioners' reasons for changing their prescribing behaviour', British Medical Journal, Vol. 312, pp. 949-952.
47. Seneviratne, S. L., Gunatilake, S. B., Adhikari, A. A. et al. (1998) 'Changing prescribing behaviour: Early low dose aspirin in suspected acute myocardial infarction', International Journal of Cardiology, Vol. 67, pp. 237-240.
48. Creswell, J. W., Fetters, M. D. and Ivankova, N. V. (2004) 'Designing a mixed methods study in primary care', Annals of Family Medicine, Vol. 2, pp. 7-12.